VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 134 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $290 | -34.4% | 66,968 | 0.0% | 0.02% | -27.3% |
| Q2 2023 | $442 | +53.5% | 66,968 | +57.6% | 0.02% | +69.2% |
| Q1 2023 | $288 | -8.3% | 42,487 | -0.0% | 0.01% | -13.3% |
| Q4 2022 | $314 | -99.9% | 42,500 | -1.6% | 0.02% | -28.6% |
| Q3 2022 | $427,000 | +33.4% | 43,200 | +46.9% | 0.02% | +50.0% |
| Q2 2022 | $320,000 | -3.6% | 29,400 | 0.0% | 0.01% | +7.7% |
| Q1 2022 | $332,000 | -36.8% | 29,400 | -12.1% | 0.01% | -18.8% |
| Q4 2021 | $525,000 | -10.1% | 33,437 | -1.8% | 0.02% | -15.8% |
| Q3 2021 | $584,000 | -20.5% | 34,037 | -0.3% | 0.02% | -20.8% |
| Q2 2021 | $735,000 | +43.3% | 34,137 | 0.0% | 0.02% | +33.3% |
| Q1 2021 | $513,000 | -36.6% | 34,137 | -44.7% | 0.02% | -35.7% |
| Q4 2020 | $809,000 | -18.3% | 61,692 | -39.8% | 0.03% | -12.5% |
| Q3 2020 | $990,000 | -40.2% | 102,465 | -29.2% | 0.03% | -28.9% |
| Q2 2020 | $1,655,000 | +9.8% | 144,658 | -0.6% | 0.04% | 0.0% |
| Q1 2020 | $1,507,000 | -22.5% | 145,505 | +22.8% | 0.04% | 0.0% |
| Q4 2019 | $1,944,000 | -0.1% | 118,465 | -19.1% | 0.04% | +2.3% |
| Q3 2019 | $1,946,000 | +21.5% | 146,430 | +28.9% | 0.04% | +22.2% |
| Q2 2019 | $1,601,000 | -24.1% | 113,630 | -0.9% | 0.04% | -16.3% |
| Q1 2019 | $2,110,000 | +106.5% | 114,647 | +193.0% | 0.04% | +95.5% |
| Q4 2018 | $1,022,000 | +9.5% | 39,128 | -3.8% | 0.02% | +29.4% |
| Q3 2018 | $933,000 | +20.4% | 40,678 | 0.0% | 0.02% | +30.8% |
| Q2 2018 | $775,000 | -1.1% | 40,678 | -12.7% | 0.01% | -7.1% |
| Q1 2018 | $784,000 | +12.3% | 46,578 | +1.3% | 0.01% | +16.7% |
| Q4 2017 | $698,000 | +552.3% | 45,999 | +666.8% | 0.01% | +500.0% |
| Q3 2017 | $107,000 | +13.8% | 5,999 | +4.0% | 0.00% | 0.0% |
| Q2 2017 | $94,000 | +16.0% | 5,767 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $81,000 | – | 5,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |